Nuvation Bio Inc.
NUVB
$2.88
-$0.02-0.69%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.36M | 10.96M | 7.87M | 2.16M | 1.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.36M | 10.96M | 7.87M | 2.16M | 1.44M |
| Cost of Revenue | 10.40M | 9.17M | 7.08M | 2.86M | 1.35M |
| Gross Profit | 3.95M | 1.79M | 795.00K | -700.00K | 88.00K |
| SG&A Expenses | 119.60M | 97.27M | 69.23M | 48.58M | 36.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 238.99M | 642.39M | 600.50M | 561.68M | 539.19M |
| Operating Income | -224.64M | -631.43M | -592.63M | -559.52M | -537.75M |
| Income Before Tax | -202.90M | -606.38M | -567.94M | -532.28M | -510.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -202.90 | -606.38 | -567.94 | -532.28 | -510.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -202.90M | -606.38M | -567.94M | -532.28M | -510.72M |
| EBIT | -224.64M | -631.43M | -592.63M | -559.52M | -537.75M |
| EBITDA | -223.59M | -630.50M | -591.94M | -559.00M | -537.34M |
| EPS Basic | -0.63 | -2.34 | -2.25 | -2.17 | -2.11 |
| Normalized Basic EPS | -0.39 | -1.47 | -1.41 | -1.36 | -1.32 |
| EPS Diluted | -0.63 | -2.35 | -2.26 | -2.17 | -2.11 |
| Normalized Diluted EPS | -0.39 | -1.47 | -1.41 | -1.36 | -1.32 |
| Average Basic Shares Outstanding | 1.29B | 1.19B | 1.07B | 956.34M | 901.71M |
| Average Diluted Shares Outstanding | 1.29B | 1.19B | 1.07B | 956.34M | 901.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |